Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018

Current Partnering
2000+ Pages - WILD10846
$2,995.00

Global Collaborative R&D Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2012-2018 report provides the reader with the following key benefits:



In-depth understanding of collaborative R&D deal trends since 2012
Analysis of the structure of collaborative R&D agreements with numerous real life case studies
Comprehensive listing of all collaborative R&D deals since 2012, together with deal terms, value and press release
Comprehensive access to actual collaborative R&D contracts entered into by the world’s life science companies
Analysis of key deal financials including headline value, upfront, milestone payments and royalty rates
Insight into the terms included in a collaborative R&D agreement, together with real world clause examples
Understand the key deal terms companies have agreed in previous deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies

'

Executive Summary



Chapter 1 – Introduction



Chapter 2 – Trends in collaborative R&D dealmaking



2.1. Introduction

2.2. Definition of collaborative R&D partnering

2.3. Success factors for collaborative R&D deals

2.4. When collaborative R&D can be useful

2.5. Attributes of collaborative R&D deals

2.6. Trends in collaborative R&D deals since 2012

2.6.1. Collaborative R&D dealmaking by year, 2012 to 2018

2.6.2. Collaborative R&D dealmaking by phase of development, 2012 to 2018

2.6.3. Collaborative R&D dealmaking by industry sector, 2012 to 2018

2.6.4. Collaborative R&D dealmaking by therapy area, 2012 to 2018

2.6.5. Collaborative R&D dealmaking by technology type, 2012 to 2018

2.6.6. Collaborative R&D dealmaking by most active company, 2012 to 2018

2.7. The future of collaborative R&D deals



Chapter 3 – Overview of collaborative R&D deal structure



3.1. Introduction

3.2. Pure versus multi-component collaborative R&D deals

3.3. Pure collaborative R&D agreement structure

3.3.1. Example collaborative R&D agreements

3.3.1.a. Case study 1: Marinus Pharmaceuticals - NovaMedica

3.3.1.b. Case study 2: Idenix Pharmaceuticals – Janssen Pharmaceuticals

3.4. Collaborative R&D as part of a wider alliance agreement

3.4.1. Example collaborative R&D agreements and their licensing clauses

3.4.1.a. Case study 3: 4D Molecular Therapeutics – UniQure

3.4.1.b. Case study 4: Kyowa Hakko Kirin – Ultragenyx Pharmaceuticals

3.4.2. Example licensing option right clauses in collaborative R&D deals

3.4.2.a. Case study 5: Forest Laboratories - Trevena

3.4.2.b. Case study 6: Abbvie – Receptos



Chapter 4 – Leading collaborative R&D deals



4.1. Introduction

4.2. Top collaborative R&D deals by value



Chapter 5 – Top 50 most active collaborative R&D dealmakers



5.1. Introduction

5.2. Top 50 most active collaborative R&D dealmakers



Chapter 6 – Collaborative R&D deal term financials



6.1. Introduction

6.2. Collaborative R&D partnering headline values

6.3. Collaborative R&D deal upfront payments

6.4. Collaborative R&D deal milestone payments

6.5. Collaborative R&D royalty rates



Chapter 7 – Collaborative R&D contract directory 2012 - 2018



7.1. Introduction

7.2. Collaborative R&D deals with contracts 2012 to 2018



Appendices



Appendix 1 – Collaborative R&D dealmaking by companies A-Z

Appendix 2 – Collaborative R&D dealmaking by industry sector

Appendix 3 – Collaborative R&D dealmaking by stage of development

Appendix 4 – Collaborative R&D dealmaking by therapy area

Appendix 5 – Collaborative R&D dealmaking by technology type



About Wildwood Ventures



Current Partnering

Current Agreements

Recent report titles from Current Partnering



TABLE OF FIGURES



Figure 1: Definition of collaborative R&D

Figure 2: Situations where collaborative R&D can prove useful

Figure 3: Key attributes of a collaborative R&D deal

Figure 4: Trends in Collaborative R&D deal announcements, 2012 to 2018

Figure 5: Collaborative R&D deals signed at each phase of development, 2012 to 2018

Figure 6: Collaborative R&D deals by industry sector, 2012 to 2018

Figure 7: Collaborative R&D deals by therapy area, 2012 to 2018

Figure 8: Collaborative R&D deals by technology type, 2012 to 2018

Figure 9: Top 50 most active collaborative R&D dealmakers, 2012 to 2018

Figure 10: Collaborative R&D agreements – what should a contract include?

Figure 11: Components of the collaborative R&D deal structure

Figure 12: Top collaborative deals by value 2012 to 2018

Figure 13: Most active collaborative R&D dealmakers 2012 to 2018

Figure 14: Collaborative R&D deals with a headline value

Figure 15: Collaborative R&D deals with an upfront value

Figure 16: Collaborative R&D deals with a milestone value

Figure 17: Collaborative R&D deals with a royalty rate value

$2,995.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838